GlassScriptPhysician profile
Travis Woodley
NPI 1396274072
$1,193.34
in general payments reported to CMS, 2019-2025
14 companies · $21.36 in 2025
The $21.36 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $520 · 2022: $52.07 · 2023: $109 · 2024: $490 · 2025: $21.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $288.01 | 2024-2025 | Dysport |
| Astrazeneca Pharmaceuticals LP | $190.81 | 2021 | |
| Abbvie INC. | $157.05 | 2024 | |
| Janssen Pharmaceuticals, INC | $152.64 | 2021 | |
| Abbott Laboratories | $94.07 | 2022-2023 | Cardiomems |
| Acella Pharmaceuticals, LLC | $61.68 | 2023-2024 | NP Thyroid 60 |
| Amgen INC. | $59.38 | 2021 | |
| Azurity Pharmaceuticals, INC. | $46.54 | 2023 | Adthyza |
| Novartis Pharmaceuticals Corporation | $37.44 | 2021 | |
| Amarin Pharma, INC. | $36.44 | 2021 | |
| Philips North America LLC | $25.93 | 2024 | (Cm9) Amb Mon & Diag Und |
| Lantheus Medical Imaging, INC. | $16.73 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.92 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Woodley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.